Clinical Trials In Connecticut

Discover hundreds of clinical trials in Connecticut.
Search clinical trials in Connecticut by city, condition or phase.

e.g. Respiratory Diseases

Connecticut•Healthy volunteers: No

Filter results

Results: 1,111

A Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants

Recruiting

Phase 3

Sponsor:

Bristol-Myers Squibb

Location:

New Haven, Los Alamitos, San Diego, Miamishow 20 more

Code:

NCT06045689

Conditions

Myelodysplastic Syndromes

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Luspatercept

Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy

Recruiting

Sponsor:

Hartford Hospital

Location:

Hartford

Code:

NCT05224089

Conditions

Bowel Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Liposomal Bupivicaine/Bupivacaine Admixture

Bupivacaine HCL

Testing the Combination of Inotuzumab Ozogamicin and Lower Dose Chemotherapy Compared to Usual Chemotherapy for Adults With B-Cell Acute Lymphoblastic Leukemia or B-Cell Lymphoblastic Lymphoma

Recruiting

Phase 2

Sponsor:

Alliance for Clinical Trials in Oncology

Location:

New Haven, Birmingham, Palo Alto, Atlantashow 53 more

Code:

NCT05303792

Conditions

B Acute Lymphoblastic Leukemia

B Lymphoblastic Lymphoma

Eligibility Criteria

Sex: All

Age: 50+

Healthy Volunteers: Not accepted

Interventions

Cyclophosphamide

Vincristine

Dexamethasone

Inotuzumab Ozogamicin

Methotrexate

Yale Steroid Enhanced Versus Exparel Nerveblock TKA RCT Study

Recruiting

Phase 2

Sponsor:

Yale University

Location:

New Haven

Code:

NCT05279092

Conditions

Total Knee Replacement

Knee Arthroplasty

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bupivacaine-Liposomal Bupivacaine

Bupivacaine -Dexamethasone Sodium Phosphate-Methylprednisolone Acetate

ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)

Recruiting

Phase 3

Sponsor:

Stealth BioTherapeutics Inc.

Location:

Danbury, Phoenix, Sun City, Huntington Beachshow 29 more

Code:

NCT06373731

Conditions

Age Related Macular Degeneration (ARMD)

Eligibility Criteria

Sex: All

Age: 55+

Healthy Volunteers: Not accepted

Interventions

Elamipretide

Placebo

Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML

Recruiting

Phase 3

Sponsor:

Arog Pharmaceuticals, Inc.

Location:

New Haven, Duarte, Los Angeles, Sacramentoshow 17 more

Code:

NCT03258931

Conditions

Newly Diagnosed FLT3 Mutated AML

Eligibility Criteria

Sex: All

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Crenolanib

Midostaurin

Cytarabine

Duanorubicin

Safety and Efficacy Study of an Interactive Wound Dressing (KC002) for the Treatment of Diabetic Foot Ulcers

Recruiting

Phase 2

Sponsor:

KeraCure

Location:

New Haven, Montgomery, Phoenix, Tucsonshow 17 more

Code:

NCT00330265

Conditions

Foot Ulcer

Diabetes

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

KC-002

Conventional Wound Therapy

SPYRAL AFFIRM Global Study of RDN with the Symplicity Spyral RDN System in Subjects with Uncontrolled HTN

Recruiting

Sponsor:

Medtronic Vascular

Location:

Hartford, Birmingham, Mesa, Phoenixshow 63 more

Code:

NCT05198674

Conditions

Hypertension

Vascular Diseases

Cardiovascular Diseases

Chronic Kidney Diseases

Diabetes Mellitus

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Renal Denervation (Symplicity Spyral™)

Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support

Recruiting

Sponsor:

Yale University

Location:

New Haven, Minneapolis, Bronx, Rochestershow 1 more

Code:

NCT04309565

Conditions

Opioid Addiction

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Transitions Clinic Network Primary Care

Standard Primary Care

Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Recruiting

Phase 1

Phase 2

Sponsor:

Aptose Biosciences Inc.

Location:

New Haven, Birmingham, Duarte, Irvineshow 11 more

Code:

NCT03850574

Conditions

Leukemia, Myeloid, Acute

Refractory AML

Relapsed Adult AML

Myelodysplastic Syndrome With Excess Blasts-2

Chronic Myelomonocytic Leukemia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tuspetinib

Venetoclax Oral Tablet

Azacitidine for Intravenous Infusion

e.g. Respiratory Diseases

Connecticut•Healthy volunteers: No

Filter results

Results: 1,111

A Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants

Recruiting

Phase 3

Sponsor:

Bristol-Myers Squibb

Location:

New Haven, Los Alamitos, San Diego, Miamishow 20 more

Code:

NCT06045689

Conditions

Myelodysplastic Syndromes

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Luspatercept

Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy

Recruiting

Sponsor:

Hartford Hospital

Location:

Hartford

Code:

NCT05224089

Conditions

Bowel Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Liposomal Bupivicaine/Bupivacaine Admixture

Bupivacaine HCL

Testing the Combination of Inotuzumab Ozogamicin and Lower Dose Chemotherapy Compared to Usual Chemotherapy for Adults With B-Cell Acute Lymphoblastic Leukemia or B-Cell Lymphoblastic Lymphoma

Recruiting

Phase 2

Sponsor:

Alliance for Clinical Trials in Oncology

Location:

New Haven, Birmingham, Palo Alto, Atlantashow 53 more

Code:

NCT05303792

Conditions

B Acute Lymphoblastic Leukemia

B Lymphoblastic Lymphoma

Eligibility Criteria

Sex: All

Age: 50+

Healthy Volunteers: Not accepted

Interventions

Cyclophosphamide

Vincristine

Dexamethasone

Inotuzumab Ozogamicin

Methotrexate

Yale Steroid Enhanced Versus Exparel Nerveblock TKA RCT Study

Recruiting

Phase 2

Sponsor:

Yale University

Location:

New Haven

Code:

NCT05279092

Conditions

Total Knee Replacement

Knee Arthroplasty

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bupivacaine-Liposomal Bupivacaine

Bupivacaine -Dexamethasone Sodium Phosphate-Methylprednisolone Acetate

ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)

Recruiting

Phase 3

Sponsor:

Stealth BioTherapeutics Inc.

Location:

Danbury, Phoenix, Sun City, Huntington Beachshow 29 more

Code:

NCT06373731

Conditions

Age Related Macular Degeneration (ARMD)

Eligibility Criteria

Sex: All

Age: 55+

Healthy Volunteers: Not accepted

Interventions

Elamipretide

Placebo

Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML

Recruiting

Phase 3

Sponsor:

Arog Pharmaceuticals, Inc.

Location:

New Haven, Duarte, Los Angeles, Sacramentoshow 17 more

Code:

NCT03258931

Conditions

Newly Diagnosed FLT3 Mutated AML

Eligibility Criteria

Sex: All

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Crenolanib

Midostaurin

Cytarabine

Duanorubicin

Safety and Efficacy Study of an Interactive Wound Dressing (KC002) for the Treatment of Diabetic Foot Ulcers

Recruiting

Phase 2

Sponsor:

KeraCure

Location:

New Haven, Montgomery, Phoenix, Tucsonshow 17 more

Code:

NCT00330265

Conditions

Foot Ulcer

Diabetes

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

KC-002

Conventional Wound Therapy

SPYRAL AFFIRM Global Study of RDN with the Symplicity Spyral RDN System in Subjects with Uncontrolled HTN

Recruiting

Sponsor:

Medtronic Vascular

Location:

Hartford, Birmingham, Mesa, Phoenixshow 63 more

Code:

NCT05198674

Conditions

Hypertension

Vascular Diseases

Cardiovascular Diseases

Chronic Kidney Diseases

Diabetes Mellitus

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Renal Denervation (Symplicity Spyral™)

Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support

Recruiting

Sponsor:

Yale University

Location:

New Haven, Minneapolis, Bronx, Rochestershow 1 more

Code:

NCT04309565

Conditions

Opioid Addiction

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Transitions Clinic Network Primary Care

Standard Primary Care

Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Recruiting

Phase 1

Phase 2

Sponsor:

Aptose Biosciences Inc.

Location:

New Haven, Birmingham, Duarte, Irvineshow 11 more

Code:

NCT03850574

Conditions

Leukemia, Myeloid, Acute

Refractory AML

Relapsed Adult AML

Myelodysplastic Syndrome With Excess Blasts-2

Chronic Myelomonocytic Leukemia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tuspetinib

Venetoclax Oral Tablet

Azacitidine for Intravenous Infusion